Volume: 35 Issue: 4

1. Impacts of infection status of hepatitis viruses and biochemical parameters of liver function on 18F-FDG uptake by the liver Page:254—257
2. 131I therapy for Graves disease: a comparative study for calculating the 131I-iodide activity based on radioactive iodine uptake formula and individualized experience method Page:272—275
3. Tumor inhibitory effects of 131I-Trastuzumab on human epidermal growth factor receptor 2 overexpressing breast cancer cells and its possible mechanisms Page:293—297
4. CT and 18F-FDG PET/CT features of pulmonary sclerosing hemangioma Page:251—253
5. Curative efficacy and influential factors of 131I treatment for lung metastases from differentiated thyroid carcinoma Page:258—261
6. Effect of taking L-T4 in bedtime vs morning on changes of serum thyroid hormone concentration in patients with hypothyroidism Page:265—267
7. Association between iodine intake and treatment outcomes of radioiodine remnant ablation in patients with papillary thyroid cancer Page:268—271
8. Diagnostic value of SPECT/CT for lumbar spondylolysis Page:280—283
9. Diagnostic value of 18F-FDG PET/CT for differentiating multiple myeloma from bone metastases with undetermined origin Page:284—288
10. In vitro study of type Ⅰ intron-mediated dual reporter gene imaging for carcinoembryonic antigen Page:298—302
11. Automated synthesis and quality analysis of 18F-FMISO based on CFN-MPS-100 module Page:303—305
12. The diagnostic value of 18F-FDG PET/CT in differentiated thyroid carcinoma Page:315—318
13. Progress of 99Tcm-labeled glucose and its analogs in tumor imaging Page:319—321
14. Progress on the clinical research of fluoro-3(2(S)-2-azetidinylmethoxy) pyridine and Iodo-3-(2(S)-azetidinylmethoxy) pyridine Page:322—325